Global healthcare AI tech secures investment - Insider Media
Summary
Clinithink also has the backing of major specialist health funds in the US.The patented technology uses AI technology to accurately read and interpret up to two million clinical documents an hour generating invaluable insights in a fraction of the time it would take clinicians to review manually. Its global clients include AstraZeneca, University of Utah, Mount Sinai, Premier Inc, and Northwell Health.Marc Goldman, chief product officer of Clinithink said: "The Development Bank has backed the business from the very early days, supporting us through various fundraising rounds on the journey to becoming an established global health-tech brand. "Its an exciting time as we grow our team and expand our position in the US market with our platform being adopted by life science, healthcare and government organisations who want to use electronic medical data to improve patient care, clinical outcomes and resource allocation. We are also encouraged by the recent announcement that the UK Government is investing \xa33.4 billion in digital initiatives to help improve NHS productivity. "Andy Morris, senior investment executive with the Development Banks tech venture team, said: "Our continued support, which now totals over \xa35m is helping the Clinithink team build a successful healthcare AI technology business that can change how the world manages patient care, by harnessing the power of healthcare data with proven AI technology.
Funding
Review available funding amount, funding date, investors, and linked company information related to Global healthcare AI tech secures investment - Insider Media in the interactive ISVWorld profile.